Parental Education for Autism
(FITBI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a new family-based treatment, called FITBI (Family-Implemented Treatment on the Behavioral Inflexibility of Children With Autism), can reduce negative behaviors and enhance positive outcomes for young children with autism spectrum disorder (ASD). Delivered remotely through video sessions, the treatment is accessible for families. Participants will receive either the FITBI treatment, which uses positive reinforcement, or parent education sessions on ASD-related topics. The trial seeks children aged 3 to 9 with a confirmed autism diagnosis who exhibit significant repetitive behaviors affecting daily life. As an unphased trial, it offers families the chance to access innovative treatment strategies that could improve their child's daily life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does mention that participants should not have changed their psychotropic medications in the last 6 weeks. This might mean that stable medication use is required.
What prior data suggests that this family-based treatment is safe for children with autism?
Research has shown that the Family-Implemented Treatment for Behavioral Inflexibility (FITBI) is generally well-received. FITBI helps parents manage repetitive and inflexible behaviors in children with autism. Conducted entirely online through telehealth, all sessions are virtual. This method is considered low risk because it uses behavioral techniques instead of medications and does not involve any physical procedures.
Specific information on negative effects from the FITBI treatment itself is not available. However, its non-invasive nature suggests it is safe for participants. Behavioral treatments like FITBI typically carry fewer risks compared to medical treatments. For those considering participation, FITBI is designed to be a supportive and safe choice for families.12345Why are researchers excited about this trial?
Researchers are excited about the Parental Education for Autism trial because it explores innovative ways to support families with children on the autism spectrum. Unlike traditional in-person therapy sessions, the FITBI treatment uses reinforcement-based learning delivered entirely via telehealth, offering flexibility and accessibility for parents. This remote approach could break down barriers to receiving care, making it easier for families to engage in consistent treatment sessions from the comfort of their own homes. By focusing on parental education and empowerment, this trial aims to enhance the family's ability to support their child, potentially leading to better outcomes for children with autism.
What evidence suggests that this trial's treatments could be effective for autism?
Research has shown that the Family-Implemented Treatment for Behavioral Inflexibility (FITBI), one of the treatments in this trial, reduces repetitive behaviors in children with autism. Studies have found that FITBI improves children's behavior by making them less rigid in their actions, with these improvements lasting for at least six months after treatment ends. Families using FITBI report feeling less stressed and observe that their children handle everyday tasks better. Overall, evidence suggests that FITBI effectively helps young children with autism manage difficult behaviors. Another treatment arm in this trial, Parent Education, provides information relevant to parenting a young child with ASD, which may also support families in managing autism-related challenges.12356
Who Is on the Research Team?
Brian Boyd, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Are You a Good Fit for This Trial?
This trial is for children aged 3 to 9.5 years with autism who show significant repetitive behavior and have been previously diagnosed with ASD. They must score above a certain level on a specific behavior scale and meet ASD criteria on two diagnostic tools. Children can't join if they've had recent changes in psychotropic meds, receive extensive ABA therapy at home, have certain genetic disorders, or engage in intense self-harm.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Remote delivery of FITBI intervention with 13 weekly sessions and 3 booster sessions over 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- FITBI
- Parental Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas
Lead Sponsor